Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Bathing for C. diff Prevention
NCT02502682Phase 2Completed
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of chlorhexidine in Clostridium difficile infection (CDI) (2 arms). Primary endpoints: Relative Risk of Clostridium Difficile Infection at 12 months and Duration of Hospital Stays at 6 days. Started Jul 2015; status: completed.
02
Drugs
chlorhexidine
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02502682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502682.